Logo

Sign in | Create an Account Cart 0
Sign In
Forgot password?
Institutional Users can Sign In here
Don't have an Account?
Create an account
 
Forgot Password
 
Thank You for Registration

Thank-you for creating an account on Longwoods.com.

As a registered user of longwoods.com you can receive the following benefits:
  • Abstracts from ALL Longwoods.com publications
  • Citation tracking and reference links to full-text articles
  • Ability to share the information through various social media outlets with a single click
  • Ability to comment on any article
  • Pay-per-View purchases of single articles or issues by credit card or paypal
  • Choice of any www.longwoods.com/newsletters delivered to your email inbox for free
  • Ability to sign up for any www.longwoods.com/events.
  • The advantage of having password access to www.Longwoods.com from any computer anywhere
Please check your e-mail and follow the instructions to activate your account. If you do not receive an e-mail, please check your junk folder.
Reset Password

Please check your e-mail and follow the instructions to reset your password.

Menu
  • Home
  • Topics
    • Access to Care
    • Aging
    • Alternative Levels of Care
    • Caregivers
    • Change Management
    • Community Care
    • COVID-19
    • Decision Making
    • Digital Health
    • Effective Teamwork
    • Equity in Healthcare
    • Governance
    • Health Human Resources
    • Health System Innovation
    • Healthcare Costs
    • Healthcare Policy
    • Healthy workplaces
    • Home Care
    • Innovations in Care
    • Leadership Development
    • Long-Term Care
    • Longwoods Healthcare Services Radio
    • Mental Health
    • Nursing Leadership
    • Pandemic Planning
    • Patient Experience
    • Patient Safety
    • Patient-Centered Care
    • Primary Care
    • Public Health
    • Quality Improvement
    • System Integration
    • Workforce Planning
  • Events
    • Longwoods Breakfast Series
    • Healthcare Rounds
    • Leadership Discussion
    • Conferences and Education
    • Healthcare Awards
  • Publications
    • Healthcare Quarterly
    • HealthcarePapers
    • Healthcare Policy
    • Nursing Leadership
    • Insights
    • Special Issues
    • White Papers
    • Longwoods Blog
    • World Health & Population
    • ElectronicHealthcare
    • Law & Governance
    • Books
  • Multimedia
    • Videos
    • Podcasts
  • Jobs
    • Longwoods Job Site
    • HR Resources Database
    • Transitions
    • Rates for Job Postings
  • Subscribe

Health & Healthcare News

Government of Canada acts to permanently control sedative drug linked to illegal drug markets

 
From: Health Canada
News release
November 19, 2025 | Ottawa, Ontario | Health Canada
Today, the Honourable Marjorie Michel, Minister of Health, announced permanent controls as of December 19, 2025, for carisoprodol, a sedative drug that has been found in illegal drug markets around the world.
Carisoprodol is used in some countries as a muscle relaxant and it has sedative effects similar to benzodiazepines. It is not authorized for sale in Canada. In light of evidence of its misuse and diversion in other countries, these new regulations will ensure that law and border enforcement continue to have the tools they need to stop its illegal importation, distribution and use. Anyone found conducting unauthorized activities with the drug could face criminal penalties under the Controlled Drug and Substances Act.
Temporary controls for carisoprodol were put in place in February 27, 2025, under a Ministerial Order for a one-year emergency basis. Since this Ministerial Order, border enforcement has successfully been able to intercept and prevent illegal shipments of carisoprodol from entering Canada.
This work is part of Canada's Border Plan, which aims to strengthen border security, including detecting and disrupting the illegal drug trade.
Quotes
"Our government is committed to continuing to strengthen Canada's robust drug controls to protect the public health and safety of Canadians. We will keep responding to new threats as they emerge and ensure that Canada's law and border enforcement agencies have the tools they need to act on illegal drugs found in our communities and at our border."
The Honourable Marjorie Michel
Minister of Health
"These permanent controls give law enforcement agencies the tools they need to stop harmful substances at our border and reinforce our government's commitment to combatting transnational organized crime and the illegal drug trade these criminals benefit from. Our Border Plan is delivering greater safety for Canadians."
The Honourable Gary Anandasangaree
Minister of Public Safety
"Today's announcement sends a clear message to organized crime—Canada is committed to eliminating illegal drugs and to keeping our communities safe. We will continue to take action to control substances linked to the illegal drug market."
Kevin Brosseau
Fentanyl Czar
Quick facts
  • Health Canada is publishing the final regulations in the Canada Gazette, Part II to control carisoprodol under Schedule IV to the Controlled Drugs and Substances Act and the Benzodiazepines and Other Targeted Substances Regulations.
  • Through Canada's Border Plan, the federal government is taking concrete action to keep communities safe on both sides of the border.
  • The World Health Organization Expert Committee on Drug Dependence published a Critical Review Report on Carisoprodol, which summarized evidence of the drug's misuse and diversion to illegal drug markets in a number of countries around the world.

Associated links
  • Order Amending Schedule IV to the Controlled Drugs and Substances Act (Carisoprodol)
  • Regulations Amending Benzodiazepines and Other Targeted Substances Regulations (Carisoprodol)
  • Strengthening Border Security

Contacts
Guillaume Bertrand
Director of Communications
Office of the Honourable Marjorie Michel
Minister of Health
guillaume.bertrand@hc-sc.gc.ca

Media Relations
Health Canada
613-957-2983
media@hc-sc.gc.ca
Public Inquiries
613-957-2991
1-866-225-0709
 

 

Contact information

Contact Us
Mailing address

260 Adelaide Street East, No. 8, Toronto ON M5A 1N1

Telephone number
416-864-9667
Fax number
416-368-4443

Subscribe Today

  • Healthcare Policy / Politiques de Santé

    Journal of health services, management and policy research

Stay Connected

Newsletter
© 2025
Longwoods Publishing Corporation
  • Institutional Users
  • About Us
  • Subscription Information
  • Advertise
  • Reprints
  • Partners
  • Terms
  • Privacy